HSP90 can regulate the activity of PPARγ in NAFLD, which is of great significance for treating NAFLD.[40] HIF-1α is a key regulatory factor that plays an active role in hypoxia. Here, HSP90AA1 is linked to metabolic dysfunction-associated steatotic liver disease.